stocksNEOGEN
NEOGEN

Neogen Chemicals Ltd.

2,025.00+74.1 (+3.80%)
9 Jul, 3:29 PM

Annual Reports and Financial Documents

Neogen Chemicals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Neogen Chemicals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Closure of Trading Window26 Jun 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window.
  • Analyst / Investor Meet12 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Analyst / Investor Meet to be held on June 23, 2026.
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20115 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Axis Mutual Fund
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20115 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Axis Mutual Fund
  • Reg.24(A)-Annual Secretarial Compliance27 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance Report for the Financial year ended March 31, 2026.
  • Analyst / Investor Meet18 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Earning''s conference call recording - Q4FY26.
  • Press Release / Media Release17 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press release- Q4FY2026
  • Code of Conduct under SEBI (PIT) Regulations, 201516 May 2026
    Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
    Outcome of Board meeting held on 16-05-2026 approving amendments to "the Code for prevention of insider trading in the securities of the Company"
  • General16 May 2026
    Outcome Of Board Meeting
    Approval of Audited financial results, recommendation of Final Dividend, Amendment to the code for prevention of insider trading in the securities of the Company and Details of outstanding ....
  • Dividend Updates16 May 2026
    Announcement under Regulation 30 (LODR)-Dividend Updates
    Recommendation of Final Dividend of Re. 1 per equity share subject to approval of shareholders at the ensuing AGM.
  • Outcome of Board Meeting16 May 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On May 16, 2026
    Approval of Audited Financial Results (Standalone and Consolidated) of the Company Company along with the Audit Reports for the Quarter and Financial Year ended March 31, 2026 and Asset ....
  • Analyst / Investor Meet12 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Earnings Conference Call scheduled to be held on Monday, May 18, 2026, at 4:30 p.m. IST for analysts/ investors to discuss the results for the quarter and financial year ended ....
  • Board Meeting12 May 2026
    Board Meeting Intimation for To Consider And Approve Audited Financial Results And Recommendation Of Final Dividend, If Any, Subject To Approval Of Shareholders.
    Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2026 ,inter alia, to consider and approve 1) Audited Financial Results ....
  • Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201130 Apr 2026
    Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 29, 2026 for Dr. Harin Haridas Kanani
  • Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201129 Apr 2026
    Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 29, 2026 for Dr. Harin Haridas Kanani
  • General28 Apr 2026
    Disclosure Pursuant To Regulation 30(9) Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
    Disclosure pursuant to regulation 30(9) read with schedule III of the SEBI (LODR) Regulations, 2015.
  • Newspaper Publication28 Apr 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Intimation to the shareholders regarding second 100 days campaign - "Saksham Niveshak" - Newspaper publication.
  • General28 Apr 2026
    Intimation To The Shareholders Regarding Second 100 Days Campaign - 'Saksham Niveshak'
    Intimation to the Shareholders regarding second 100 days campaign - "Saksham Niveshak"
  • Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A27 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201120 Apr 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Cadamba Solutions Pvt Ltd

Frequently Asked Questions

Where can I download the annual report of Neogen Chemicals Ltd.?
Annual reports of Neogen Chemicals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Neogen Chemicals Ltd.?
Quarterly earnings results and presentations of Neogen Chemicals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Neogen Chemicals Ltd. publish earnings call transcripts?
Earnings call transcripts of Neogen Chemicals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Neogen Chemicals Ltd.?
Investor presentations and annual day presentations of Neogen Chemicals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Neogen Chemicals Ltd.?
Corporate announcements and regulatory filings of Neogen Chemicals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Neogen Chemicals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Neogen Chemicals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Neogen Chemicals Ltd.?
The ISIN (International Securities Identification Number) of Neogen Chemicals Ltd. is INE136S01016. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Neogen Chemicals Ltd. listed?
Neogen Chemicals Ltd. is listed on NSE and BSE. The NSE symbol is NEOGEN and the BSE code is -.
Where can I find the shareholding pattern of Neogen Chemicals Ltd.?
The quarterly shareholding pattern of Neogen Chemicals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Neogen Chemicals Ltd. on Sharpely?
Share price data for Neogen Chemicals Ltd. is updated as of 9 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.